Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 121–135 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4630 CARD14 Gene Pityriasis Rubra Pilaris Genetic Test This diagnostic test evaluates the entire coding region of the CARD14 gene for pathogenic variants associated with Pityriasis rubra pilaris (PRP).	Whole blood (EDTA), extracted DNA, or FTA card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CARD14 gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Suspected Pityriasis rubra pilaris (PRP)", "Differential diagnosis of inflammatory skin disorders", "Family history of PRP"] Measurement technique Confirm with laboratory Codes LOINC: 93923-0 ICD-10: L44.0 Clinical summary This diagnostic test evaluates the entire coding region of the CARD14 gene for pathogenic variants associated with Pityriasis rubra pilaris (PRP).
TEST-4609 CARD14 Gene Psoriasis Type 2 Genetic Test This test evaluates the entire coding region of the CARD14 gene for pathogenic variants associated with psoriasis and psoriatic arthritis.	Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CARD14 gene coding region variants", "Pathogenic mutations linked to psoriasis/psoriatic arthritis"] Parameters [] Preparation ["Genetic counselling is mandatory prior to sample collection"] Indications ["Clinical diagnosis of psoriasis", "Familial risk assessment", "Personalised biologic therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 94220-5 ICD-10: L40.0 Clinical summary This test evaluates the entire coding region of the CARD14 gene for pathogenic variants associated with psoriasis and psoriatic arthritis.
TEST-1746 Cardiac Channelopathy Gene Panel Test This test identifies pathogenic variants in over 30 cardiac ion channel genes associated with inherited arrhythmia syndromes and sudden cardiac death.	Peripheral blood, Amniotic fluid, Chorionic villi	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in cardiac ion channel genes", "Copy Number Variations (CNVs) in relevant genes"] Parameters [] Preparation [] Indications ["Individuals with unexplained syncope", "Family history of sudden cardiac death", "Suspected inherited arrhythmia", "Asymptomatic relatives of a mutation-positive proband", "Patients with drug-induced QT prolongation"] Measurement technique Confirm with laboratory Codes LOINC: 81311-2 ICD-10: I49.9 Clinical summary This test identifies pathogenic variants in over 30 cardiac ion channel genes associated with inherited arrhythmia syndromes and sudden cardiac death.
TEST-469 Carrier Screening (Extended Genetic Panel) Test This test identifies carrier status for over 500 severe recessive and X-linked genetic conditions using NGS and MLPA.	Peripheral whole blood	4 weeks (full analysis with genetic counselling)	7,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Carrier status for >500 genes", "Recessive and X-linked genetic variants"] Parameters [] Preparation [] Indications ["Family planning", "Preconception screening", "Identifying risk for inherited genetic conditions"] Measurement technique Confirm with laboratory Codes LOINC: 51960-6 ICD-10: Z14.8, Z31.5 Clinical summary This test identifies carrier status for over 500 severe recessive and X-linked genetic conditions using NGS and MLPA.
TEST-4080 CASQ2 Gene Catecholaminergic Polymorphic Ventricular Tachycardia Type 2 Genetic Test This genetic test identifies pathogenic variants in the CASQ2 gene associated with catecholaminergic polymorphic ventricular tachycardia type 2 (CPVT2).	Peripheral whole blood or buccal swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CASQ2 gene", "Copy Number Variations (CNVs) in the CASQ2 gene"] Parameters [] Preparation ["Pre-genetic counseling session is essential", "Provide complete clinical history", "Avoid discontinuing heart medications without cardiologist’s advice"] Indications ["Individuals with exercise-induced syncope or palpitations", "Family history of CPVT2 or sudden cardiac death", "Risk stratification for sudden cardiac arrest", "Genetic counseling for families with suspected CPVT2"] Measurement technique Confirm with laboratory Codes LOINC: 82123-2 ICD-10: I47.2, Z87.89 Clinical summary This genetic test identifies pathogenic variants in the CASQ2 gene associated with catecholaminergic polymorphic ventricular tachycardia type 2 (CPVT2).
TEST-261 Cattle Genome Sequencing (30X Coverage) Test This test provides a high-resolution whole-genome sequence of bovine samples.	Whole blood (EDTA) or extracted DNA (≥2 µg, A260/A280 1.8–2.0)	5 weeks	25,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Whole bovine genome sequence", "Single-nucleotide variants (SNVs)"] Parameters [] Preparation [] Indications ["Comparative oncology research", "Genetic trait mapping", "Zoonotic disease research"] Measurement technique Confirm with laboratory Codes LOINC: 94044-2 ICD-10: Z13.79 Clinical summary This test provides a high-resolution whole-genome sequence of bovine samples.
TEST-5653 CAV3 Gene Rippling Muscle Disease Genetic Test This genetic test identifies mutations in the CAV3 gene associated with rippling muscle disease.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAV3 gene mutations", "Pathogenic variants (point mutations, small indels, copy number variations)"] Parameters [] Preparation ["No fasting required", "No special preparation needed"] Indications ["Suspected rippling muscle disease", "Familial genetic counselling", "Risk stratification"] Measurement technique Confirm with laboratory Codes LOINC: 21687-4 ICD-10: G71.0 Clinical summary This genetic test identifies mutations in the CAV3 gene associated with rippling muscle disease.
TEST-4951 CD19 Gene Common Variable Immunodeficiency Type 3 (CVID3) Genetic Test This test identifies pathogenic or likely pathogenic variants in the CD19 gene associated with Common Variable Immunodeficiency Type 3 (CVID3). It employs Next-Generation Sequencin...	Whole blood (EDTA), extracted DNA, or one drop of blood on FTA card	21–28 Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD19 gene variants", "Copy number variations (CNV) in CD19 gene"] Parameters [] Preparation ["No fasting required", "No medication changes necessary for sample collection", "Inform phlebotomist if taking anticoagulant therapy"] Indications ["Diagnosis of Common Variable Immunodeficiency Type 3 (CVID3)", "Family cascade screening for CVID3", "Targeted therapy guidance"] Measurement technique Confirm with laboratory Codes LOINC: 94233-9 ICD-10: D83.8 Clinical summary This test identifies pathogenic or likely pathogenic variants in the CD19 gene associated with Common Variable Immunodeficiency Type 3 (CVID3). It employs Next-Generation Sequencing (NGS) with Sanger confirmation.
TEST-3185 CD36 Gene (Platelet Glycoprotein IV Deficiency) Genetic Test This genetic test identifies pathogenic variants in the CD36 gene associated with platelet glycoprotein IV deficiency.	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD36 gene pathogenic variants", "Platelet Glycoprotein IV deficiency"] Parameters [] Preparation ["Mandatory pre-genetic counseling session", "Pedigree mapping"] Indications ["Suspected platelet glycoprotein IV deficiency", "Unexplained bleeding", "Family history of bleeding disorder"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: D69.1 Clinical summary This genetic test identifies pathogenic variants in the CD36 gene associated with platelet glycoprotein IV deficiency.
TEST-1970 CDKN2B / MEN1 Genetic Screening (Multiple Endocrine Neoplasia Type 1) Test This genetic test identifies pathogenic variants in the CDKN2B and MEN1 genes associated with Multiple Endocrine Neoplasia Type 1 (MEN1) syndrome and related conditions.	Whole blood (EDTA) or FTA card dried blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in CDKN2B gene", "Pathogenic variants in MEN1 gene", "Copy Number Variations (CNV) in CDKN2B and MEN1 genes"] Parameters [] Preparation ["No fasting required.", "Compulsory genetic counselling session prior to testing.", "Provide full clinical history and family pedigree.", "Ensure FTA card samples are kept dry and away from direct heat."] Indications ["Individuals with clinical features suggestive of MEN1 syndrome.", "Individuals with a first-degree relative diagnosed with MEN1 syndrome.", "Individuals with a family history of pancreatic neuroendocrine tumors or familial atypical multiple mole melanoma.", "Pre-symptomatic screening in high-risk families."] Measurement technique Confirm with laboratory Codes LOINC: 94046-2 ICD-10: E31.2 Clinical summary This genetic test identifies pathogenic variants in the CDKN2B and MEN1 genes associated with Multiple Endocrine Neoplasia Type 1 (MEN1) syndrome and related conditions.
TEST-2014 CEBPA Germline Mutation Genetic Test for AML This genetic test evaluates for inherited mutations in the CEBPA gene associated with an increased risk of developing acute myeloid leukemia (AML).	Whole blood (3–5 mL EDTA), extracted DNA (>1 µg), or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CEBPA gene mutations", "Pathogenic variants in the CEBPA coding region"] Parameters [] Preparation ["No fasting required", "Continue regular medications unless otherwise directed", "Avoid clotted or haemolysed samples", "Inform if blood transfusion received in past 2 weeks"] Indications ["Family history of AML", "Personal history suggestive of familial AML predisposition"] Measurement technique Confirm with laboratory Codes LOINC: 41629-0 ICD-10: Z15.09 Clinical summary This genetic test evaluates for inherited mutations in the CEBPA gene associated with an increased risk of developing acute myeloid leukemia (AML).
TEST-571 CEBPA Mutation Detection Test This test identifies pathogenic mutations within the CEBPA gene, which are significant prognostic markers in Acute Myeloid Leukemia (AML).	Whole Blood (Lavender Top EDTA Tube)	10 Working Days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CEBPA gene mutations (biallelic and monoallelic)", "DNA sequence variations"] Parameters [] Preparation ["Complete Genomics Clinical Information Requisition Form (Form 20)", "No fasting required"] Indications ["Diagnosis and risk stratification of Acute Myeloid Leukemia (AML)", "Prognostic assessment in AML", "Guiding therapeutic decisions in AML"] Measurement technique Confirm with laboratory Codes LOINC: 91770-4 ICD-10: C92.00 Clinical summary This test identifies pathogenic mutations within the CEBPA gene, which are significant prognostic markers in Acute Myeloid Leukemia (AML).
TEST-6069 CEL Gene MODY8 Genetic Test This test evaluates the CEL gene for pathogenic variants associated with Maturity-Onset Diabetes of the Young type 8 (MODY8).	Blood, Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CEL gene pathogenic variants", "MODY8 diagnosis"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Suspected Maturity-Onset Diabetes of the Young (MODY)", "Family history of monogenic diabetes", "Diabetes diagnosis unclear"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E13.9 Clinical summary This test evaluates the CEL gene for pathogenic variants associated with Maturity-Onset Diabetes of the Young type 8 (MODY8).
TEST-516 Cell Line Authentication DNA Test This test verifies the identity of human cell lines using STR DNA analysis.	Extracted DNA, Cell Pellet, Whole Blood (FTA card), Tissue/Tumor	10–12 days	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Short Tandem Repeat (STR) DNA profile"] Parameters [] Preparation ["Follow specific sample collection guidelines for DNA, Cell Pellet, Whole Blood, or Tissue/Tumor.", "Avoid repeated freeze-thaw cycles.", "Contact team if pre-sample conditions are uncertain."] Indications ["Verification of cell line identity", "Detection of cell line cross-contamination", "Ensuring research integrity", "Regulatory compliance for research", "Forensic casework"] Measurement technique Confirm with laboratory Codes LOINC: 81281-2 ICD-10: Z13.89 Clinical summary This test verifies the identity of human cell lines using STR DNA analysis.
TEST-6200 CFTR Gene Cystic Fibrosis Genetic Test This test evaluates the entire CFTR gene for pathogenic variants associated with cystic fibrosis.	Peripheral whole blood (EDTA)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CFTR gene sequence", "Pathogenic variants in CFTR exons and splice sites"] Parameters [] Preparation ["No special preparation needed", "Genetic counselling before sample collection is recommended"] Indications ["Diagnosis of cystic fibrosis", "Carrier screening", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 48002-3 ICD-10: E84.9 Clinical summary This test evaluates the entire CFTR gene for pathogenic variants associated with cystic fibrosis.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories